Latin America Focus M8 specializes in registering, commercializing, and prolonging the life of medicines in Latin America, presenting a clear regional growth opportunity for partners looking to enter or expand in LATAM markets.

Strategic Partnerships The company actively forms partnerships with global pharma players and offers end-to-end support from market entry to sales and marketing, enabling collaborators to leverage local expertise without building a LATAM infrastructure.

Recent Licenses Recent exclusive licensing deals for Qelbree in Latin America and ongoing partnerships with Daewoong and Marinomed indicate a robust deal flow and a proven ability to monetize partner products in the region.

Proven Commercial Readiness With a go-to-market focus, sales & marketing execution, and market optimization capabilities, M8 can accelerate partner launches, ensure regulatory compliance, and maximize product visibility in LATAM.

Strong Financials & Scale Revenue is in the hundreds of millions with substantial funding, suggesting financial stability to support co-development, risk-sharing arrangements, and longer-term partnerships with multinational and midsize innovators.